Stay updated on Tulisokibart in SSc-ILD Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart in SSc-ILD Clinical Trial page.

Latest updates to the Tulisokibart in SSc-ILD Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the clinical-trial record for the tulisokibart Phase 2 study in systemic sclerosis-associated interstitial lung disease, including its eligibility criteria, study design, outcome measures, and locations.SummaryDifference97%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe page remains a ClinicalTrials.gov 403 Forbidden error page. The footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error with the standard error content. Previously visible sections such as sponsor/investigator details, IPD-sharing information, and locations have been removed or hidden.SummaryDifference19%

- Check59 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a backend/documentation update rather than a change to trial information.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision tag changed from v3.6.5 to v3.6.6, indicating an updated edition of the page content. This update does not appear to modify study details or participant-facing information.SummaryDifference0.0%

Stay in the know with updates to Tulisokibart in SSc-ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart in SSc-ILD Clinical Trial page.